Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1724-6059
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Drug–drug interactions between sucroferric oxyhydroxide and losartan, furosemide, omeprazole, digoxin and warfarin in healthy subjects ; volume:27 ; number:6 ; day:4 ; month:4 ; year:2014 ; pages:659-666 ; date:12.2014
Journal of nephrology ; 27, Heft 6 (4.4.2014), 659-666, 12.2014
- Creator
-
Chong, Edward
Kalia, Veena
Willsie, Sandra
Winkle, Peter
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40620-014-0080-1
- URN
-
urn:nbn:de:101:1-2019063011490765017254
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Chong, Edward
- Kalia, Veena
- Willsie, Sandra
- Winkle, Peter
- SpringerLink (Online service)
Other Objects (12)
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions
Drug-drug interactions. Things to do in pain management
Case report: Medical cannabis—warfarin drug-drug interaction
Drug-drug interactions and risk of bleeding among inpatients on warfarin therapy: a prospective observational study
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
A Minimal Information Model for Potential Drug-Drug Interactions